- Home
- FBIO vs PAI Comparison
FBIO vs PAI Comparison
Compare FBIO & PAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FBIO | PAI |
|---|---|---|
| Founded | 2006 | 1973 |
| Country | United States | United States |
| Employees | 101 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 104.6M | 118.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | FBIO | PAI |
|---|---|---|
| Price | $3.28 | $12.14 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $16.50 | N/A |
| AVG Volume (30 Days) | ★ 809.2K | 14.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.78% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $29.71 | N/A |
| Revenue Next Year | $49.34 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.33 | $11.41 |
| 52 Week High | $4.53 | $13.22 |
Technical Indicators
Market Signals| Indicator | FBIO | PAI |
|---|---|---|
| Relative Strength Index (RSI) | 46.73 | 27.39 |
| Support Level | $2.47 | $12.10 |
| Resistance Level | $3.96 | $12.61 |
| Average True Range (ATR) | 0.23 | 0.14 |
| MACD | -0.01 | -0.06 |
| Stochastic Oscillator | 21.12 | 5.33 |
Price Performance
Historical ComparisonAbout FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.
About PAI Western Asset Investment Grade Income Fund Inc.
Western Asset Investment Grade Income Fund Inc is a closed-end diversified investment company. The company designed as a long-term investment and not as a trading vehicle. The fund seeks a high level of current income, consistent with prudent investment risk, through investment in a diversified portfolio of debt securities. Its portfolio is invested in securities which may be convertible into or exchangeable for, or carry warrants to purchase, common stock or other equity interests; and preferred stock.